(Q33421351)

English

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

Jeffrey S Weber

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Bartosz Chmielowski

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Inge Marie Svane

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Jean-Jacques Grob

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Paolo Antonio Ascierto

18

object named as

Paolo A Ascierto

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

4

object named as

F Stephen Hodi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

28

object named as

James Larkin

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Sandra P D'Angelo

2

object named as

Sandra P D'Angelo

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

David Minor

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Ralf Gutzmer

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Christoph Hoeller

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Nikhil I Khushalani

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Wilson H Miller

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Christopher D Lao

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Gerald P Linette

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Kenneth F Grossmann

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Jessica C Hassel

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Peter Mohr

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Angela M Krackhardt

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Christine Horak

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Alexandre Lambert

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Arvin S Yang

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Mario Sznol

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

18 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

375-384

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970076-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970076-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue expression of PD-L1 mediates peripheral T cell tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970076-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970076-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970076-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970076-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970076-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970076-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970076-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970076-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety, efficacy, and biomarkers of nivolumab with vaccine in ipilimumab-refractory or -naive melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970076-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970076-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970076-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Nivolumab in previously untreated melanoma without BRAF mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970076-8

7 January 2021

based on heuristic

inferred from DOI database lookup

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970076-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Nivolumab plus ipilimumab in advanced melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970076-8

7 January 2021

based on heuristic

inferred from DOI database lookup

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970076-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970076-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Developing a common language for tumor response to immunotherapy: immune-related response criteria using unidimensional measurements

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970076-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970076-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970076-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of retreatment with ipilimumab in patients with pretreated advanced melanoma who progressed after initially achieving disease control

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970076-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of immune-related adverse events and kinetics of response with ipilimumab

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970076-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(15)70076-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25795410%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33421351&oldid=2033419159"